InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001608538-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-03-04 2026-03-02 ELV Haytaian Peter D EVP, Pres Carelon, CarelonRx A - Grant $0.00 +2,865 27.7K +12% $0
M 2026-03-04 2026-03-02+ ELV Haytaian Peter D EVP, Pres Carelon, CarelonRx F - Tax $291.35 -1,647 24.8K -6% -$479.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-02 A A 2,865 $0.00 27,668 D — — (F2) Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
2 Common Common Stock 2026-03-03 F D 446 $284.03 27,222 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
3 Common Common Stock 2026-03-02 F D 1,201 $294.07 24,803 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.